Table 3.
Factors | Nonsurvivors (n = 26) |
Survivors (n = 466) |
Unadjusted OR (95% CI), P value |
Adjusted OR (95% CI), P value |
---|---|---|---|---|
Age (yr) | 7.5 (5.9–10) | 7.6 (5–10) | 1.02 (0.92–1.14), P = .69 |
- |
Gender | ||||
Male | 15 (58) | 223 (48) | 0.67 (0.3–1.5), P = .33 |
- |
Female | 11 (42) | 243 (52) | ||
Dengue severity* | ||||
Compensated DSS | 18 (69) | 410 (88) | 3.95 (1.73–9.0), P = .001 |
- |
Decompensated DSS | 8 (31) | 56 (12) | ||
Respiratory rate (breaths/min) | 30 (24–35) | 26 (24–30) | 1.03 (0.98–1.08), P = .19 |
- |
Severe bleeding* | ||||
No | 7 (27) | 418 (90) | 23.6 (9.5–59.1), P < .001 |
4.14 (1.25–13.7), |
Yes | 19 (73) | 48 (10) | P = .02 | |
Severe liver transaminases* | ||||
No | 8 (31) | 399 (86) | 13.4 (5.6–32.1), P < .001 |
- |
Yes | 18 (69) | 67 (14) | ||
Peak hematocrit level (%) | 48 (42–52) | 48 (45–51) | 0.97 (0.91–1.04), P = .41 |
- |
Low platelet cell count, (< 20,000 cells × 109/L) |
||||
No | 12 (46) | 361 (77) | 4.0 (1.8–8.91), P < .001 |
- |
Yes | 14 (54) | 105 (23) | ||
Serum creatinin (µmol/L) | 68 (58–123) | 50 (42–58) | 1.03 (1.02–1.05), P < .001 |
- |
High VIS (> 30) No Yes |
5 (19) 21 (81) |
452 (97) 14 (3) |
135 (45–412), P < .001 |
36.2 (10.7–122.3), P < .001 |
Square root of cumulative amount of infusion fluid from referral hospitals and 24h PICU admission (mL/kg)† | 16 (14–18) | 11 (9–13) | 1.36 (1.21–1.52), P < .001 |
1.18 (1.04–1.34), P = .01 |
Summary statistics are median (IQR) for continuous variables and frequency (%) for categorical data.
CI = confidence interval; DSS = dengue shock syndrome; OR = odds ratio, PICU = pediatric intensive care unit; VIS = vasoactive-inotropic score, WHO = World Health Organization.
These factors were defined by the WHO dengue guidelines in 2009.
Standardized covariate of the cumulative amount of fluid from referral hospitals and within 24h PICU admission by square root.